Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Blue Gold LtdBGL · Entity 8074 | Chief Financial Officer | June 01, 2026 | June 02, 2026 |
| CANNAPHARMARX, INC.CPMD · Entity 8539 | Director · 10% owner | April 20, 2018 | June 26, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Blue Gold Ltd
Report date June 01, 2026 · Filed June 02, 2026
This filing explicitly reported no securities owned.
CANNAPHARMARX, INC.
Report date April 20, 2018 · Filed June 26, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Convertible Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 31,000,000 |
Reported balance
After 2018-04-20 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-04-20 · Other · Acquired 10,000 · Balance 31,000,000 F2: The Reporting Person subscribed and paid for 30,000 Series A Convertible Preferred Shares directly from the Issuer. Subsequently, he verbally agreed to sell 10,000 of these shares, but the buyer failed to pay for the shares and the agreement was terminated. F1: The conversion righes of the Series A Convertible Preferred Stock do not expire and can be converted at any time. |
Filing footnotes · ownership attribution and instrument terms
F1: The conversion righes of the Series A Convertible Preferred Stock do not expire and can be converted at any time.
F2: The Reporting Person subscribed and paid for 30,000 Series A Convertible Preferred Shares directly from the Issuer. Subsequently, he verbally agreed to sell 10,000 of these shares, but the buyer failed to pay for the shares and the agreement was terminated.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 23, 2019 Filed Feb 3, 2020 23:19 UTC Amendment | CANNAPHARMARX, INC. CPMD · Entity 8539 | SaleSeries A Convertible Preferred Stock · Derivative | 1,200 | $1.00 Strike: $0.00 | $1,200.00 |
DisclosureSEC source: 0001683168-20-000334 · ownership.xml · derivative · entry 2 SAMUELSON JAMES F · CIK 0001198070 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,800 Underlying: Common Stock · 1,500,000 shares Expires not disclosed F1 · shares: Each share of the Series A Convertible Preferred Stock are convertible into 1,250 shares of Common Stock of the Issuer. F3 · shares: These shares were sold to the Company's Vice-President of Strategic Development and its legal counsel, respectively. F2 · derivative.expiration_date: The conversion rights of the Series A Convertible Preferred Stock do not expire and can be exercised at any time. F1 · balance_after: Each share of the Series A Convertible Preferred Stock are convertible into 1,250 shares of Common Stock of the Issuer. Read SEC document |
| April 23, 2019 Filed Feb 3, 2020 23:19 UTC Amendment | CANNAPHARMARX, INC. CPMD · Entity 8539 | SaleSeries A Convertible Preferred Stock · Derivative | 4,000 | $1.00 Strike: $0.00 | $4,000.00 |
DisclosureSEC source: 0001683168-20-000334 · ownership.xml · derivative · entry 1 SAMUELSON JAMES F · CIK 0001198070 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 5,000,000 shares Expires not disclosed F1 · shares: Each share of the Series A Convertible Preferred Stock are convertible into 1,250 shares of Common Stock of the Issuer. F3 · shares: These shares were sold to the Company's Vice-President of Strategic Development and its legal counsel, respectively. F2 · derivative.expiration_date: The conversion rights of the Series A Convertible Preferred Stock do not expire and can be exercised at any time. F1 · balance_after: Each share of the Series A Convertible Preferred Stock are convertible into 1,250 shares of Common Stock of the Issuer. Read SEC document |
| April 23, 2018 Filed Feb 3, 2020 21:55 UTC | CANNAPHARMARX, INC. CPMD · Entity 8539 | SaleSeries A Convertible Preferred Stock · Derivative | 1,200 | $1.00 Strike: $0.00 | $1,200.00 |
DisclosureSEC source: 0001683168-20-000325 · ownership.xml · derivative · entry 2 SAMUELSON JAMES F · CIK 0001198070 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,800 Underlying: Common Stoc · 1,500,000 shares Expires not disclosed F1 · shares: Each share of the Series A Convertible Preferred Stock are convertible into 1,250 shares of Common Stock of the Issuer. F3 · shares: These shares were sold to the Company's Vice-President of Strategic Development and its legal counsel, respectively. F2 · derivative.expiration_date: The conversion rights of the Series A Convertible Preferred Stock do not expire and can be exercised at any time. F1 · balance_after: Each share of the Series A Convertible Preferred Stock are convertible into 1,250 shares of Common Stock of the Issuer. Read SEC document |
| April 23, 2018 Filed Feb 3, 2020 21:55 UTC | CANNAPHARMARX, INC. CPMD · Entity 8539 | SaleSeries A Convertible Preferred Stock · Derivative | 4,000 | $1.00 Strike: $0.00 | $4,000.00 |
DisclosureSEC source: 0001683168-20-000325 · ownership.xml · derivative · entry 1 SAMUELSON JAMES F · CIK 0001198070 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stoc · 5,000,000 shares Expires not disclosed F1 · shares: Each share of the Series A Convertible Preferred Stock are convertible into 1,250 shares of Common Stock of the Issuer. F3 · shares: These shares were sold to the Company's Vice-President of Strategic Development and its legal counsel, respectively. F2 · derivative.expiration_date: The conversion rights of the Series A Convertible Preferred Stock do not expire and can be exercised at any time. F1 · balance_after: Each share of the Series A Convertible Preferred Stock are convertible into 1,250 shares of Common Stock of the Issuer. Read SEC document |
| April 20, 2018 Filed Jun 26, 2020 17:26 UTC | CANNAPHARMARX, INC. CPMD · Entity 8539 | OtherConvertible Preferred Stock · Derivative | 10,000 | $1.00 Strike: $0.00 | $10,000.00 |
DisclosureSEC source: 0001683168-20-002077 · ownership.xml · derivative · entry 1 SAMUELSON JAMES F · CIK 0001198070 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,000,000 Underlying: Common Stock · 12,500,000 shares Expires not disclosed F2 · kind: The Reporting Person subscribed and paid for 30,000 Series A Convertible Preferred Shares directly from the Issuer. Subsequently, he verbally agreed to sell 10,000 of these shares, but the buyer failed to pay for the shares and the agreement was terminated. F1 · derivative.expiration_date: The conversion righes of the Series A Convertible Preferred Stock do not expire and can be converted at any time. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.